Article · 31 Dec 2025
ArticlePublished 20 Feb 2024
The Future of Targeted Therapy for Leiomyosarcoma: A Promising Horizon
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Leiomyosarcoma (LMS), a malignant soft tissue tumor arising from smooth muscle cells, presents a significant therapeutic challenge due to its aggressive nature and limited treatment options. Conventional treatments such as surgery, chemotherapy, and radiation have shown limited efficacy, prompting the exploration of novel therapeutic strategies. Among these, targeted therapy has emerged as a promising approach, offering the potential to improve outcomes for patients with LMS. In this article, we delve into the current landscape of targeted therapy for LMS and explore the promising future directions in this field.
Keywords
Subjects
Oncology & CancerSurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Archives of Surgical Oncology.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Surgical Oncology
- SubjectOncology & Cancer
- SubjectSurgery
- BylineArticles whose byline prints “Vlad Bratucu”
